CFM Wealth Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,049
Closed -$280K 150
2024
Q1
$280K Sell
4,049
-7,218
-64% -$457K 0.06% 133
2023
Q4
$834K Sell
11,267
-176
-2% -$11.5K 0.19% 84
2023
Q3
$781K Hold
11,443
0.2% 80
2023
Q2
$1.07M Hold
11,443
0.26% 78
2023
Q1
$776K Hold
11,443
0.21% 82
2022
Q4
$567K Hold
11,443
0.17% 103
2022
Q3
$372K Buy
11,443
+393
+4% +$16.2K 0.12% 120
2022
Q2
$435K Hold
11,050
0.13% 116
2022
Q1
$773K Sell
11,050
-107
-1% -$7.82K 0.19% 91
2021
Q4
$910K Buy
11,157
+566
+5% +$50K 0.2% 88
2021
Q3
$1.01M Buy
10,591
+1,125
+12% +$119K 0.25% 78
2021
Q2
$1.18M Buy
9,466
+144
+2% +$17.2K 0.31% 67
2021
Q1
$1.23M Hold
9,322
0.37% 62
2020
Q4
$1.24M Buy
9,322
+808
+9% +$97.7K 0.39% 56
2020
Q3
$868K Buy
8,514
+1,757
+26% +$152K 0.32% 67
2020
Q2
$587K Buy
6,757
+468
+7% +$37.4K 0.22% 77
2020
Q1
$365K Buy
6,289
+4,949
+369% +$402K 0.17% 91
2019
Q4
$120K Buy
+1,340
New +$118K 0.04% 188

Other funds holding EXAS

CFM Wealth Partners's EXAS Position: Q2 2024 in Review

CFM Wealth Partners sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 4,049 shares — an estimated $280K sold.

CFM Wealth Partners first reported a position in EXAS in Q4 2019 and held it in 18 quarters. The position peaked at $1.24M in Q4 2020. 542 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • CFM Wealth Partners reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • CFM Wealth Partners sold 4,049 Exact Sciences shares in Q2 2024, an estimated $280K.
  • CFM Wealth Partners first reported a position in Exact Sciences in Q4 2019 and held it in 18 quarters.
  • CFM Wealth Partners's Exact Sciences position peaked at $1.24M in Q4 2020.
  • 542 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on CFM Wealth Partners's 13F filing for Q2 2024, filed 18 Jul 2024.